SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950162-08-000095
Filing Date
2008-02-13
Accepted
2008-02-13 15:32:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 DOR BIOPHARMA INC./SIGMA TAU FINANZIARIA SCHEDULE 13G/A NO. 1 dorsigmataufin13gano1_021308.htm SC 13G/A 227508
  Complete submission text file 0000950162-08-000095.txt   229488
Mailing Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628
Business Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628 609-538-8200
DOR BIOPHARMA INC (Subject) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-39976 | Film No.: 08604319
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA SUDAFRICA 20 00144 ROME ITALY
Business Address
SIGMA TAU FINANZIARIA SPA (Filed by) CIK: 0001092601 (see all company filings)

Fiscal Year End: 1231
Type: SC 13G/A